Skip to main content

Closed

APRE: Aprea Therapeutics, Inc. Financial Statements & Revenue | finqOS

Healthcare · Biotechnology

52W Range

6thpctl

Volume

0.40×avg

Market Cap

4.03MUSD

P/E Ratio

-0.4TTM

Div Yield

-ann

Aprea Therapeutics, Inc.

APRENASDAQ Global Select·USD·Closed

Aprea Therapeutics, Inc.

APRENASDAQ·USD·Closed

$0.62

−2.36%

$0.62

−$0.02 (2.36%)

52W Range

6thpctl

Volume

0.40×avg

Mkt Cap

4.03MUSD

P/E

-0.4TTM

Div Yield

–ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings